日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial

认知障碍与绝经前和绝经后妇女的化学内分泌治疗与内分泌治疗:RxPONDER随机临床试验的二次分析

Kang, Irene M; Forschmiedt, Jamie K; Loch, Michelle M; Lew, Danika L; Barlow, William E; Gralow, Julie R; Meric-Bernstam, Funda; Albain, Kathy S; Hayes, Daniel F; Lin, Nancy U; Perez, Edith A; Goldstein, Lori J; Rastogi, Priya; Schott, Anne F; Baehner, Rick; Sharma, Priyanka; Tripathy, Debasish; Pusztai, Lajos; Hortobagyi, Gabriel N; Kalinsky, Kevin; Henry, N Lynn

Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT

完善辅助性 CDK4/6 抑制剂的风险评估,超越临床试验纳入标准:根据 ADAPT 整合复发评分和内分泌反应性

Braun, Michael; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Luedtke-Heckenkamp, Kerstin; Darsow, Maren; Forstbauer, Helmut; Polata, Silke; Grischke, Eva-Maria; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Zu Eulenburg, Christine; Kates, Ronald; Burmeister, Sandy; Graeser, Monika; Wuerstlein, Rachel; Baehner, Rick; Christgen, Matthias; Kreipe, Hans Heinrich; Harbeck, Nadia

Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer

开发和验证 RSClinN+ 工具,用于预测激素受体阳性、淋巴结阳性乳腺癌的预后和化疗获益

Pusztai, Lajos; Hoag, Jess R; Albain, Kathy S; Barlow, William E; Stemmer, Salomon M; Meisner, Allison; Hortobagyi, Gabriel N; Shak, Steven; Rae, James M; Baehner, Rick; Sharma, Priyanka; Kalinsky, Kevin M

Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)

HR阳性HER2阴性早期乳腺癌的内分泌反应评估:WSG ADAPTcycle试验中局部与中心Ki67测量的一致性(n = 5292)

Hamann, M; Christgen, M; Gluz, O; Nitz, U; Kuemmel, S; Braun, M; Thill, M; Wuerstlein, R; Wimberger, P; Hartkopf, A; Schem, C; Zaiss, M; Bjelic-Radisic, V; Just, M; Veselinovic, K; Vincent, M; Graeser, M; Krauss, K; Hoffmann, O; Lüdtke-Heckenkamp, K; Kates, R E; Zu Eulenburg, C; Jóźwiak, K; Burmeister, S; Hauptmann, M; Baehner, F; Schmid, P; Kreipe, H-H; Harbeck, N

HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN

HER2低表达状态作为一种独特的乳腺癌亚型:是谬论还是事实?对WSG试验WSG-ADAPT-HR+/HER2-、WSG-PlanB和WSG-ADAPT-TN的分析

Schmidt, Gilda; Gluz, Oleg; Christgen, Matthias; Reinisch, Mattea; Kümmel, Sherko; Nitz, Ulrike; Braun, Michael; Aktas, Bahriye; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Mahlberg, Rolf; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Stefek, Andrea; Wuerstlein, Rachel; Graeser, Monika; Jóźwiak, Katarzyna; Burmeister, Sandy; Zu Eulenburg, Christine; Lauseker, Michael; Kolberg-Liedtke, Cornelia; Prat, Aleix; Schmid, Peter; Baehner, Rick; Kreipe, Hans Heinrich; Solomayer, Erich-Franz; Harbeck, Nadia

Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data

采用12基因Oncotype DX结肠复发评分®检测指导治疗的II期结肠癌患者的治疗和临床结果:真实世界数据

Brenner, B; Shulman, K; Hubert, A; Man, S; Geva, R; Ben-Aharon, I; Fennig, S; Mishaeli, M; Yarom, N; Bar-Sela, G; Brenner, R; Shai, A; Baehner, F L; Russell, C; Soussan-Gutman, L; Voet, H; Bareket-Samish, A; Liebermann, N

Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomy

前列腺基因组评分阳性切缘与根治性前列腺切除术后复发的相关性

Nourmohammadi Abadchi, Sanaz; Salles, Daniela C; Flannery, Cynthia; Sama, Varun; Baehner, Frederick L; Zambon, Joao P; Mendes, Adrianna A; DePaula Oliveira, Lia; Han, Misop; Jing, Yuezhou; Partin, Alan W; Trock, Bruce J; Lotan, Tamara L

BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization

BRCA1/2 突变携带者与一般乳腺癌人群(N = 799,986):基于 21 基因检测的分子特征分析

Yerushalmi, Rinat; Pomerantz, Adi; Lewin, Ron; Paluch-Shimon, Shani; Soussan-Gutman, Lior; Baehner, Frederick L; Voet, Hillary; Bareket-Samish, Avital; Kedar, Inbal; Goldberg, Yael; Peretz-Yablonski, Tamar; Kadouri, Luna

Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial

SWOG S8814试验中内分泌治疗敏感性指数和21基因乳腺癌复发评分的评估

Speers, Corey W; Symmans, W Fraser; Barlow, William E; Trevarton, Alex; The, Stephanie; Du, Lili; Rae, James M; Shak, Steven; Baehner, Rick; Sharma, Priyanka; Pusztai, Lajos; Hortobagyi, Gabriel N; Hayes, Daniel F; Albain, Kathy S; Godwin, Andrew; Thompson, Alastair

Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay

利用Oncotype DX检测进行定量RT-PCR,对HER2低表达浸润性乳腺癌进行分子分型。

Lin, Hao-Kuen; Can, Thuy; Kahn, Adriana; Flannery, Cynthia A; Hoag, Jess; Akkunuri, Alekhya; Bailey, Helen; Baehner, Rick; Pusztai, Lajos; Rozenblit, Mariya